Clinical implications of the p53 gene

David Sidransky, Monica Hollstein

Research output: Contribution to journalReview articlepeer-review

Abstract

The capacity for malignant growth is acquired by the stepwise accumulation of defects in specific genes regulating cell growth and tissue homeostasis. Although several hundred genes are known to control growth, molecular genetic studies in cancer show that few of these are consistently involved in the natural history of human cancer, and those typically in only certain types of malignancy. Prospects for development of molecular-based diagnostic and therapeutic strategies with widespread application did not look promising, until it was realized that the p53 tumor suppressor gene was defective in approximately half of all malignancies. This discovery generated research efforts of unparalleled intensity to determine how p53 functions at the molecular level, and how to apply this knowledge to clinical ends.

Original languageEnglish (US)
Pages (from-to)285-301
Number of pages17
JournalAnnual review of medicine
Volume47
DOIs
StatePublished - May 20 1996

Keywords

  • Apoptosis
  • Cell cycle
  • Clonality
  • Molecular diagnostics
  • Mutation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Clinical implications of the p53 gene'. Together they form a unique fingerprint.

Cite this